Shareholder alert: weiss law investigates abiomed, inc.

New york , nov. 1, 2022 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of abiomed, inc. ("abiomed" or the "company") (nasdaq: abmd), in connection with its proposed tender offer by johnson & johnson (nyse: jnj). under the tender offer, the company's shareholders will receive $380.00 in cash, reflecting an enterprise value of approximately $16.6 billion, and a non-tradeable contingent value right (cvr) entitling the holder to receive up to $35.00 for each share of abiomed common stock owned.
ABMD Ratings Summary
ABMD Quant Ranking